Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.92 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.92 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MGAM | O43451 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6077608 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL6078816 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL6078811 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL11799710 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL9231331 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| SCHEMBL20838342 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL23832483 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| Perseitol SCHEMBL20567548 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| SCHEMBL22283330 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A | |
| SCHEMBL12344326 | 1.00 | TDP1 (1.00) | TDP1LMNAL3MBTL1KDM4EPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2634137-B1 | ORGANIC/INORGANIC HYBRIDS AND PROCESS FOR PRODUCING THEM | NAT INST FOR MATERIALS SCIENCE (JP) | 2016-12-28 | — | — | EP | claimed |
| US-9284490-B2 | Organic/inorganic hybrids, and process of producing them | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2016-03-15 | — | — | US | claimed |
| EP-2634137-A1 | ORGANIC/INORGANIC HYBRID AND PROCESS FOR PRODUCING SAME | National Institute for Materials Science (JP) | 2013-09-04 | — | — | EP | claimed |
| US-20130221295-A1 | ORGANIC/INORGANIC HYBRIDS, AND PROCESS OF PRODUCING THEM | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2013-08-29 | — | — | US | claimed |
| US-5273865-A | 50% Silver bromide, developer, buffer, complexing agent, antifogging agent contrasting agent and an antioxidant having four to eight hydroxy groups | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-12-28 | — | — | US | claimed |
| EP-0459103-A1 | Photographic color developing composition and method for processing a silver halide color photographic element | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-12-04 | — | — | EP | claimed |
| US-12576362-B2 | Method for concentrating raw material solution, and system for concentrating raw material solution | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| US-12515382-B2 | Production method for dip-molded article | ZEON CORPORATION (JP) | 2026-01-06 | — | — | US | disclosed |
| EP-3753702-B1 | PRODUCTION METHOD FOR DIP-MOLDED ARTICLE | ZEON CORP (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-20250215146-A1 | POLYOL COMPOSITION FOR SOFT POLYURETHANE FOAM MOLDING, COMPOSITION FOR SOFT POLYURETHANE FOAM MOLDING, SOFT POLYURETHANE FOAM, AND PRODUCTION METHOD FOR SAME | TOSOH CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| WO-2025069725-A1 | POLISHING COMPOSITION, CONCENTRATED SOLUTION OF POLISHING COMPOSITION, AND POLISHING METHOD | 株式会社フジミインコーポレーテッド | 2025-04-03 | — | — | WO | disclosed |
| US-12215057-B2 | Cement additive, cement admixture, cement composition, molded body, and method for improving strength of molded body | NIPPON SHOKUBAI CO., LTD. (JP) | 2025-02-04 | — | — | US | disclosed |
| WO-2024181146-A1 | PRODUCTION METHOD FOR DIP-MOLDED BODY | 日本ゼオン株式会社 | 2024-09-06 | — | — | WO | disclosed |
| EP-0407089-B1 | COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1993-03-10 | — | — | EP | disclosed |
| EP-0459103-A1 | Photographic color developing composition and method for processing a silver halide color photographic element | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-12-04 | — | — | EP | disclosed |
| EP-0407089-A2 | Cosmetic composition | UNILEVER PLC (GB) | 1991-01-09 | — | — | EP | disclosed |
| US-4102702-A | BY PRECIPITATION FROM AQUEOUS SOLUTION CONTAINING REDUCIBLE SILVER SALT, ALKALI METAL HYDROXIDE, AMMONIA AND POLYHYDRIC ALCOHOL | PEACOCK INDUSTRIES, INC. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4046922-A | Shelf stable, semi-moist simulated egg | THE QUAKER OATS COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-3962462-A | Stabilization of dry pet food | THE QUAKER OATS COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3950545-A | Baked product containing protein and vitamins and process for preparing same | THE QUAKER OATS COMPANY (US) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576362-B2 | Method for concentrating raw material solution, and system for concentrating raw material solution | MAX, OTC, OAT | TDP1 3850/4885LMNA 1454/4885L3MBTL1 3914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.